Benitec Biopharma (BNTC) Enterprise Value: 2019-2025
Historic Enterprise Value for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2025 value amounting to $299.5 million.
- Benitec Biopharma's Enterprise Value rose 1958.61% to $299.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $299.5 million, marking a year-over-year increase of 1042.18%. This contributed to the annual value of $299.5 million for FY2025, which is 1958.61% up from last year.
- Latest data reveals that Benitec Biopharma reported Enterprise Value of $299.5 million as of Q2 2025, which was up 48.68% from $201.5 million recorded in Q1 2025.
- In the past 5 years, Benitec Biopharma's Enterprise Value registered a high of $299.5 million during Q2 2025, and its lowest value of -$18.2 million during Q3 2023.
- For the 3-year period, Benitec Biopharma's Enterprise Value averaged around $74.6 million, with its median value being $14.1 million (2024).
- Per our database at Business Quant, Benitec Biopharma's Enterprise Value soared by 3,630.08% in 2021 and then crashed by 200.47% in 2022.
- Benitec Biopharma's Enterprise Value (Quarterly) stood at $9.1 million in 2021, then crashed by 163.81% to -$5.8 million in 2022, then slumped by 108.92% to -$12.1 million in 2023, then surged by 1,875.12% to $214.9 million in 2024, then surged by 1,958.61% to $299.5 million in 2025.
- Its Enterprise Value stands at $299.5 million for Q2 2025, versus $201.5 million for Q1 2025 and $214.9 million for Q4 2024.